Safety and Efficacy of Liraglutide in Parkinson's Disease

Clinical trial NCT02953665 · COMPLETED

Trial details

NCT number: NCT02953665
Sponsor: Cedars-Sinai Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2017-04-03
Primary completion: 2022-08-03
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.